Q2
Elekta, Varian settle trade theft, rep-poaching lawsuit
Invacare sinks and rebounds on restated Q2, sale of medical recliner business
Echo Therapeutics climbs back up after post-earnings share slide
Second-quarter losses soar for Derma Sciences
Second-quarter losses soared for Derma Sciences (NSDQ:DSCI), but the wound care company still managed to beat Wall Street’s earnings expectations by 4¢.
Princeton, N.J.-based Derma Sciences reported losses of $7.3 million, or 43¢ per share, on sales of $18.1 million for the 3 months ended June 30. Losses grew 59.8% despite a 3.1% top-line gain, compared with Q2 2012.
European restructuring costs hit Q1 earnings for Steris
Steris posts a mixed bag in Q1, strong sales and earnings offset by restructuring costs and per-share earnings that miss expectations by 1 cent.
Steris (NYSE:STE) took a hit during its fiscal 1st quarter from a $9.2 million tax charge over its restructuring in Europe, but posted a more than 9% top-line gain.
Solta tanks amid mixed quarter, CEO shuffle
Despite a relatively strong 2nd-quarter financial report, shares of Solta Medical (NSDQ:SLTM) took a dive last week, losing more than 16% of its share value in a matter of days.
Wall Street rewards Cardiovascular Systems following strong 4th quarter
Mela guts staff after Q2 losses force ‘restructuring’
Mela Sciences (NSDQ:MELA) shares slid 13 points on Wall Street yesterday after a devastating 2nd quarter forced the company to layoff 25% of its staff and impose an overall "restructuring of its operations."
CareFusion’s Q4, FY2013 earnings rise despite sales slides
CareFusion (NYSE:CFN) eked out earnings increases for its fiscal 4th quarter and the full year, despite posting sales declines during both periods.
Hansen Medical slips on missed Q2 numbers
Hansen Medical (NSDQ:HNSN) shares slipped today after the medical device company missed expectations on Wall Street with wider losses and a more than 5% sales decline.